244 related articles for article (PubMed ID: 34234436)
1. Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl
Ullah A; Chen G; Hussain A; Khan H; Abbas A; Zhou Z; Shafiq M; Ahmad S; Ali U; Usman M; Raza F; Ahmed A; Qiu Z; Zheng M; Liu D
Int J Nanomedicine; 2021; 16():4451-4470. PubMed ID: 34234436
[TBL] [Abstract][Full Text] [Related]
2. Cyclam-Modified PEI for Combined VEGF siRNA Silencing and CXCR4 Inhibition To Treat Metastatic Breast Cancer.
Zhou Y; Yu F; Zhang F; Chen G; Wang K; Sun M; Li J; Oupický D
Biomacromolecules; 2018 Feb; 19(2):392-401. PubMed ID: 29350899
[TBL] [Abstract][Full Text] [Related]
3. CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation.
Ullah A; Wang K; Wu P; Oupicky D; Sun M
Int J Nanomedicine; 2019; 14():2927-2944. PubMed ID: 31118614
[No Abstract] [Full Text] [Related]
4. Cholesterol Modification Enhances Antimetastatic Activity and siRNA Delivery Efficacy of Poly(ethylenimine)-Based CXCR4 Antagonists.
Wu P; Luo X; Wu H; Yu F; Wang K; Sun M; Oupicky D
Macromol Biosci; 2018 Nov; 18(11):e1800234. PubMed ID: 30259651
[TBL] [Abstract][Full Text] [Related]
5. Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis.
Park K; Hong SW; Hur W; Lee MY; Yang JA; Kim SW; Yoon SK; Hahn SK
Biomaterials; 2011 Jul; 32(21):4951-8. PubMed ID: 21481451
[TBL] [Abstract][Full Text] [Related]
6. A new approach based on CXCR4-targeted combination liposomes for the treatment of liver fibrosis.
Ullah A; Chen G; Yibang Z; Hussain A; Shafiq M; Raza F; Liu D; Wang K; Cao J; Qi X
Biomater Sci; 2022 May; 10(10):2650-2664. PubMed ID: 35420075
[TBL] [Abstract][Full Text] [Related]
7. Probing the Effect of miRNA on siRNA-PEI Polyplexes.
Meneksedag-Erol D; Tang T; Uludağ H
J Phys Chem B; 2015 Apr; 119(17):5475-86. PubMed ID: 25844922
[TBL] [Abstract][Full Text] [Related]
8. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary delivery of polyplexes for combined PAI-1 gene silencing and CXCR4 inhibition to treat lung fibrosis.
Ding L; Zhu C; Yu F; Wu P; Chen G; Ullah A; Wang K; Sun M; Li J; Oupický D
Nanomedicine; 2018 Aug; 14(6):1765-1776. PubMed ID: 29777878
[TBL] [Abstract][Full Text] [Related]
10. Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis.
Liu CH; Chan KM; Chiang T; Liu JY; Chern GG; Hsu FF; Wu YH; Liu YC; Chen Y
Mol Pharm; 2016 Jul; 13(7):2253-62. PubMed ID: 27224003
[TBL] [Abstract][Full Text] [Related]
11. Silica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applications.
Buchman YK; Lellouche E; Zigdon S; Bechor M; Michaeli S; Lellouche JP
Bioconjug Chem; 2013 Dec; 24(12):2076-87. PubMed ID: 24180511
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of corneal myofibroblast development through nanoparticle-mediated soluble transforming growth factor-β type II receptor (sTGFβRII) gene transfer.
Sharma A; Rodier JT; Tandon A; Klibanov AM; Mohan RR
Mol Vis; 2012; 18():2598-607. PubMed ID: 23112572
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats.
Li G; Xie Q; Shi Y; Li D; Zhang M; Jiang S; Zhou H; Lu H; Jin Y
J Gene Med; 2006 Jul; 8(7):889-900. PubMed ID: 16652398
[TBL] [Abstract][Full Text] [Related]
14. Bioreducible crosslinked polyelectrolyte complexes for MMP-2 siRNA delivery into human vascular smooth muscle cells.
Lee D; Kim D; Mok H; Jeong JH; Choi D; Kim SH
Pharm Res; 2012 Aug; 29(8):2213-24. PubMed ID: 22477074
[TBL] [Abstract][Full Text] [Related]
15. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.
Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK
ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990
[TBL] [Abstract][Full Text] [Related]
16. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier.
Wang J; Dou B; Bao Y
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238
[TBL] [Abstract][Full Text] [Related]
17. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression.
Huang HY; Kuo WT; Chou MJ; Huang YY
J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641
[TBL] [Abstract][Full Text] [Related]
19. Silencing of GFP expression in human mesenchymal stem cells using quaternary polyplexes of siRNA-PEI with glycosaminoglycans and albumin.
Herrera LC; Shastri VP
Acta Biomater; 2019 Nov; 99():397-411. PubMed ID: 31541736
[TBL] [Abstract][Full Text] [Related]
20. Facial amphipathic deoxycholic acid-modified polyethyleneimine for efficient MMP-2 siRNA delivery in vascular smooth muscle cells.
Kim D; Lee D; Jang YL; Chae SY; Choi D; Jeong JH; Kim SH
Eur J Pharm Biopharm; 2012 May; 81(1):14-23. PubMed ID: 22311297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
